U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc. - 576934 - 03/16/2023
  1. Warning Letters

CLOSEOUT LETTER

Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc. MARCS-CMS 576934 —

Delivery Method:
VIA UNITED PARCEL SERVICE
Product:
Medical Devices

Recipient:
Recipient Name
Jonathan Chapman
Recipient Title
President and Chief Financial Officer
Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc.

4600 Anson Blvd
Whitestown, IN 46075
United States

Issuing Office:
Division of Medical Device and Radiological Health Operations East

United States


Dear Mr. Chapman:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter, CMS# 576934, dated July 31, 2019 for your firm’s Indianapolis, IN location. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,
/S/
Gina M. Brackett
Director, Compliance Branch
Office of Medical Devices & Radiological Health Division One - East

 
Back to Top